Yoshimichi Haruna

1.1k total citations
31 papers, 928 citations indexed

About

Yoshimichi Haruna is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yoshimichi Haruna has authored 31 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 15 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Yoshimichi Haruna's work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (9 papers). Yoshimichi Haruna is often cited by papers focused on Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (9 papers). Yoshimichi Haruna collaborates with scholars based in Japan and United States. Yoshimichi Haruna's co-authors include Ko Saito, Michael A. Nalesnik, Michael A. Gerber, Stephen W. Spaulding, Hideyuki Fusamoto, Akinori Kasahara, Norio Hayashi, Takenobu Kamada, Tsutomu Kanda and Swan N. Thung and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Yoshimichi Haruna

30 papers receiving 903 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yoshimichi Haruna 648 504 270 131 81 31 928
Helge Bell 593 0.9× 639 1.3× 188 0.7× 68 0.5× 40 0.5× 13 902
K Tanikawa 506 0.8× 438 0.9× 351 1.3× 79 0.6× 67 0.8× 64 855
Yoshitaka Takuma 699 1.1× 680 1.3× 285 1.1× 130 1.0× 60 0.7× 31 1.0k
Dekai Qiu 667 1.0× 634 1.3× 263 1.0× 122 0.9× 81 1.0× 32 991
Sang Jun Suh 646 1.0× 596 1.2× 246 0.9× 197 1.5× 102 1.3× 50 1.1k
Tomoo Yamazaki 406 0.6× 537 1.1× 140 0.5× 173 1.3× 57 0.7× 59 753
Valérie Bourcier 875 1.4× 813 1.6× 207 0.8× 112 0.9× 115 1.4× 26 1.2k
Sung Won Lee 618 1.0× 559 1.1× 220 0.8× 173 1.3× 210 2.6× 65 1.2k
Anna Baiges 669 1.0× 644 1.3× 300 1.1× 129 1.0× 18 0.2× 49 949
Jurgen Ludwig 730 1.1× 507 1.0× 517 1.9× 40 0.3× 131 1.6× 12 945

Countries citing papers authored by Yoshimichi Haruna

Since Specialization
Citations

This map shows the geographic impact of Yoshimichi Haruna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimichi Haruna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimichi Haruna more than expected).

Fields of papers citing papers by Yoshimichi Haruna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimichi Haruna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimichi Haruna. The network helps show where Yoshimichi Haruna may publish in the future.

Co-authorship network of co-authors of Yoshimichi Haruna

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimichi Haruna. A scholar is included among the top collaborators of Yoshimichi Haruna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimichi Haruna. Yoshimichi Haruna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haruna, Yoshimichi, Takayuki Yakushijin, & Seiichi Kawamoto. (2021). Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study. Cancer Medicine. 10(3). 914–922. 18 indexed citations
3.
Haruna, Yoshimichi, Noriko Hasegawa, Kazuho Imanaka, Seiichi Kawamoto, & Atsuo Inoue. (2017). Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma. Journal of Cancer. 8(11). 1988–1994. 13 indexed citations
4.
5.
Inoue, Yuko, Naoki Hiramatsu, Tsugiko Oze, et al.. (2011). Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin. Journal of Medical Virology. 83(3). 419–427. 4 indexed citations
6.
7.
Namikoshi, Tamehachi, Natsuo Tomita, Masataka Satoh, et al.. (2007). Olmesartan Ameliorates Renovascular Injury and Oxidative Stress in Zucker Obese Rats Enhanced by Dietary Protein. American Journal of Hypertension. 20(10). 1085–1091. 35 indexed citations
8.
Oze, Tsugiko, Naoki Hiramatsu, Natsuko Tsuda, et al.. (2006). Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Journal of Gastroenterology. 41(9). 862–872. 16 indexed citations
9.
Kaneko, Akira, Shinichiro Watanabe, Akihiro Nakama, et al.. (2005). Efficacy and problems in bezafibrate treatment for PBC. Kanzo. 46(4). 200–207. 1 indexed citations
10.
Nishida, Tsutomu, Shingo Tsuji, Masahiko Tsujii, et al.. (2005). Oral Glucose Tolerance Test Predicts Prognosis of Patients with Liver Cirrhosis. The American Journal of Gastroenterology. 101(1). 70–75. 116 indexed citations
11.
Nishida, Tsutomu, Shingo Tsuji, Masahiko Tsujii, et al.. (2004). Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. Journal of Gastroenterology and Hepatology. 19(3). 258–265. 53 indexed citations
12.
Mori, Kenji & Yoshimichi Haruna. (2003). Hepatocellular carcinoma appearing after eight-year and six-month-long sustained viral response by interferon therapy for chronic hepatitis. Kanzo. 44(6). 296–300. 1 indexed citations
13.
Haruna, Yoshimichi, et al.. (2001). Detection of Hepatitis C Virus in the Bile and Bile Duct Epithelial Cells of Hepatitis C Virus-Infected Patients. Hepatology. 33(4). 977–980. 23 indexed citations
14.
Haruna, Yoshimichi, Takeshi Miyamoto, Masaki Shibata, & Tatsuo Kanda. (2000). Administration of interferon alpha suppositories to HCV-infected patients suppressed HCV replication associated with decreased CD4/CD8 ratio and elevated 2 ’-5 ’ oligoadenylate synthetase activity in peripheral blood.. Hepatology. 32(4). 370. 2 indexed citations
15.
Haruna, Yoshimichi, Takashi Miyamoto, Reiko Yasunami, et al.. (2000). Human leukocyte antigen DRB1 1302 protects against bile duct damage and portal lymphocyte infiltration in patients with chronic hepatitis C. Journal of Hepatology. 32(5). 837–842. 11 indexed citations
16.
Haruna, Yoshimichi, Ko Saito, Stephen W. Spaulding, Michael A. Nalesnik, & Michael A. Gerber. (1996). Identification of bipotential progenitor cells in human liver development. Hepatology. 23(3). 476–481. 169 indexed citations
17.
Hytiroglou, Prodromos, Srikanta Dash, Yoshimichi Haruna, et al.. (1995). Detection of Hepatitis B and Hepatitis C Viral Sequences in Fulminant Hepatic Failure of Unknown Etiology. American Journal of Clinical Pathology. 104(5). 588–593. 18 indexed citations
18.
Haruna, Yoshimichi, et al.. (1994). Expression of hepatitis C virus in hepatocellular carcinoma. Cancer. 73(9). 2253–2258. 37 indexed citations
19.
Haruna, Yoshimichi, Norio Hayashi, Naoki Hiramatsu, et al.. (1993). Detection of hepatitis C virus RNA in liver tissues by an in situ hybridization technique. Journal of Hepatology. 18(1). 96–100. 63 indexed citations
20.
Haruna, Yoshimichi, Norio Hayashi, Nobukazu Yuki, et al.. (1992). Serum Pre-Sl and Pre-S2 Antigens as Prognostic Markers in Interferon Therapy for Chronic Hepatitis B. Scandinavian Journal of Gastroenterology. 27(7). 615–619. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helge Bell Breakdown of academic impact, for papers by K Tanikawa Breakdown of academic impact, for papers by Yoshitaka Takuma Breakdown of academic impact, for papers by Dekai Qiu Breakdown of academic impact, for papers by Sang Jun Suh Breakdown of academic impact, for papers by Tomoo Yamazaki Breakdown of academic impact, for papers by Valérie Bourcier Breakdown of academic impact, for papers by Sung Won Lee Breakdown of academic impact, for papers by Anna Baiges Breakdown of academic impact, for papers by Jurgen Ludwig
Rankless by CCL
2026